Human PilotPubMed ID: 15201867·2004
Erectile Response to Intranasal PT-141 in Men with and without Erectile Dysfunction
Diamond DA, Dondiego WE, Rosen RC, et al.
Journal of Urology, 2004 · n = 24
Key finding
Intranasal PT-141 induced erectile response in 79% of treated men including 67% of sildenafil-nonresponders (n=9).
Summary
Pilot study of intranasal PT-141 in men with ED, including sildenafil-refractory patients. Measured penile rigidity and tumescence.
Read the study
The full citation, abstract, and (when available) the full text can be accessed on PubMed. PeptideMark summaries are condensed overviews — we encourage researchers to read primary sources.
View on PubMedRelated compound
More research on PT-141
Comparison of PT-141 and Flibanserin for Female Sexual Desire Disorder: An Indirect Treatment Comparison
Sexual Medicine Reviews · 2022 · Review
Blood Pressure and Cardiovascular Effects of Bremelanotide in Hypertensive Versus Normotensive Women
Journal of Sexual Medicine · 2021 · Human RCT
Long-Term Safety and Efficacy of Bremelanotide: 1-Year Extension Study in Women with HSDD
The Journal of Sexual Medicine · 2021 · Human Pilot
RECONNECT-1: A Randomized Controlled Trial of Bremelanotide for Female Sexual Desire Disorder
The Journal of Sexual Medicine · 2020 · Human RCT
RECONNECT-2: Phase 3 Trial of Bremelanotide in Premenopausal Women with Generalized Hypoactive Sexual Desire Disorder
The Journal of Sexual Medicine · 2020 · Human RCT